EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeit

Genetic variations, clinical presentation and treatment outcome of isolated growth hormone deficiency type I and II: case series and review of the literature

Ran Li, Yiying Yang, Xudong Bao, Meiping Chen, Hongbo Yang, Fengying Gong, Hanze Du, Hui Pan, Huijuan Zhu

Endocrine · 2024

DOI: 10.1007/s12020-024-04102-w ↗

Kurz gefasst

Fallbericht in der Zeitschrift Endocrine, 2024. Verfasst von Ran Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases …. Hauptthemen laut MEDLINE: Human Growth Hormone, Dwarfism, Pituitary. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Chinese Academy of Medical Science Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To report a case series of four patients with isolated growth hormone deficiency (IGHD) type I from two Chinese pedigrees and to elucidate phenotype-genotype correlation of IGHD type I and II with GH1 gene alterations in the literature. METHODS: Whole exome sequencing (WES) was performed and a literature review was conducted. RESULTS: Four patients presented with extreme growth retardation (height -4.74 to -6.50 SDS) and undetectable peak growth hormone (GH) during GH stimulating test. WES revealed a novel homozygous nonsense mutation, c.316delC (p.L106Cfs*35), in GH1 gene in the the first pedigree. Deletions of exon 1-5 in GH1 gene were identified in the second pedigree. Ideal catch-up growth after GH treatment was achieved. 94 patients with IGHD type I and 240 patients with IGHD type II were included in literature review. Patients with IGHD type I exhibited younger age (3.2 vs 6.0 years, P < 0.001), more severe growth retardation (median height -6.50 vs -3.84 SDS, P < 0.001), lower peak GH levels (0.05 vs 1.70 ng/ml, P < 0.001) and a higher dosage of GH (0.22 vs 0.17 mg/kg/week, P = 0.012) compared to patients with IGHD type II. Gross deletions constituted 72.3% of IGHD type I cases, while splicing mutations and missense mutations comprised 54.2% and 45.0% of IGHD type II cases. In patients with IGHD type I harboring gross deletion, an early age of diagnosis correlated with both a higher height SDS at diagnosis and a better response after GH treatment. Height SDS after GH treatment in patients with IGHD type II carrying splicing mutations was negatively correlated with age at diagnosis. CONCLUSION: We identified two GH1 gene mutations, c.316delC (p.L106Cfs*35) and deletions of exon 1-5 in four Chinese patients with IGHD type I. They had a good response to GH treatment and gained satisfactory height improvement. Early diagnosis and initiating treatment may lead to a better prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneDwarfism, PituitaryHumansMaleFemaleChildChild, PreschoolTreatment OutcomePedigreeAdolescentExome Sequencing

Stichwörter der Autor:innen

GH1 geneCatch-up growthIsolated growth hormone deficiencyShort stature

Substanzen

Human Growth Hormone

Autor:innen und Institutionen

  • Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital, Chinese Academy of Medical Scie…
  • Eight-Year Program of Clinical Medicine, Chinese Academy of Medical Science and Peking Union Medical College, 100730, Beijing, China.
  • Department of Pediatric, Chinese Academy of Medical Science and Peking Union Medical College, 100730, Beijing, China.

Förderung

  • Chinese Academy of Medical Science Innovation Fund for Medical Sciences

Zitieren

APA

Li, R., Yang, Y., Bao, X., Chen, M., Yang, H., Gong, F., Du, H., Pan, H., & Zhu, H. (2024). Genetic variations, clinical presentation and treatment outcome of isolated growth hormone deficiency type I and II: case series and review of the literature. Endocrine. https://doi.org/10.1007/s12020-024-04102-w

Vancouver

Li R, Yang Y, Bao X, Chen M, Yang H, Gong F, et al. Genetic variations, clinical presentation and treatment outcome of isolated growth hormone deficiency type I and II: case series and review of the literature. Endocrine. 2024. doi:10.1007/s12020-024-04102-w

BibTeX
@article{Li2024,
  author = {Li, Ran and Yang, Yiying and Bao, Xudong and Chen, Meiping and Yang, Hongbo and Gong, Fengying and Du, Hanze and Pan, Hui and Zhu, Huijuan},
  title = {Genetic variations, clinical presentation and treatment outcome of isolated growth hormone deficiency type I and II: case series and review of the literature},
  journal = {Endocrine},
  year = {2024},
  doi = {10.1007/s12020-024-04102-w}
}
Kostenlos starten →